Found 4887 chains in Genus chains table. Displaying 351 - 400. Applied filters: Proteins

Search results query: 4-Layer Sandwich

Total Genus Sequence Length pdb Title
63 211 5l5iK Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9
63 241 5l62G Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
64 234 5lf4E Human 20s proteasome complex with delanzomib at 2.0 angstrom
70 243 5l61F Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14
58 226 5l61H Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14
68 233 5l5xM Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914
57 204 5m2bI Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19
57 195 5l5zJ Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib
66 240 5m2bC Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19
66 250 5l6cA Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
72 230 5lchA Vim-2 metallo-beta-lactamase in complex with (s)-1-allyl-2-(3-methoxyphenyl)-3-oxoisoindoline-4-carboxylic acid (compound 42)
59 196 5l5vN 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
67 211 5l60K Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
59 196 5l63N Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
58 204 5l5pI Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
57 204 5lttI Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924
70 244 5l68B Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14
70 244 5l61B Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14
69 244 5l63B Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
65 250 5l69A Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
66 250 5lttA Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924
67 233 5l5vM 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
65 200 5lezK Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom
61 195 5l5vJ 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
67 216 5lf7M Human 20s proteasome complex with ixazomib at 2.0 angstrom
66 233 5l68M Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14
70 243 5lttF Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924
62 241 5l67G Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924
66 250 5l5vA 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
58 196 5l60N Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
54 196 5lf7J Human 20s proteasome complex with ixazomib at 2.0 angstrom
58 204 5l68I Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14
57 195 5l60J Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
66 250 5l68A Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14
60 231 5l61E Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14
68 242 5l5yD Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib
67 233 5m2bM Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19
59 226 5l5zH Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib
69 237 5le5C Native human 20s proteasome at 1.8 angstrom
62 220 5lf3H Human 20s proteasome complex with bortezomib at 2.1 angstrom
72 240 5l5xC Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914
68 240 5l6aC Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
63 241 5l5yG Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib
69 244 5l5vB 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
64 234 5lf0E Human 20s proteasome complex with epoxomicin at 2.4 angstrom
64 244 5lezG Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom
64 227 5lzp0 Binding of the c-terminal gqyl motif of the bacterial proteasome activator bpa to the 20s proteasome
67 242 5l62D Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
65 216 5lezM Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom
66 237 5lf3C Human 20s proteasome complex with bortezomib at 2.1 angstrom